Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Elicio Therapeutics, Inc. (ELTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Elicio Therapeutics, Inc. (ELTX), most recent 12 months reported: net loss $37.84M, free cash flow -$36.97M. Latest balance sheet on file: liquid cash $23.48M, total debt $9.54M, net cash $13.95M. From SEC filings. Others in Pharmaceutical Preparations: Dogwood Therapeutics, Inc. · Dyne Therapeutics, Inc. · EDESA BIOTECH, INC. · Eledon Pharmaceuticals, Inc. · ENLIVEN THERAPEUTICS, INC. · ENVERIC BIOSCIENCES, INC. · GALMED PHARMACEUTICALS LTD. · EUPRAXIA PHARMACEUTICALS INC.

Stock screener

Watchlist